Please login to the form below
Oragenics
This page shows the latest Oragenics news and features for those working in and with pharma, biotech and healthcare.
Meeting with resistance
Oragenics believes that large-scale, cost-effective production of clinical grade MU1140-S will be possible by use of DPOLTTM. ... It appears unlikely that NAI-107 is as far advanced in development as Oragenics' MU1140-S.
Latest news
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Dr Alan Joslyn becomes president and CEO of Oragenics
He will also serve on the company’s board of directors. Florida-based Oragenics has appointed Dr Alan Joslyn as its new president, chief executive officer and member of the board ... We believe that his passion for technology will help ensure that
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
- HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
No results were found
PMHub
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to...
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
